148 related articles for article (PubMed ID: 24468680)
1. PANDER transgenic mice display fasting hyperglycemia and hepatic insulin resistance.
Robert-Cooperman CE; Dougan GC; Moak SL; Athanason MG; Kuehl MN; Bell-Temin H; Stevens SM; Burkhardt BR
J Endocrinol; 2014 Mar; 220(3):219-31. PubMed ID: 24468680
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice.
Wilson CG; Schupp M; Burkhardt BR; Wu J; Young RA; Wolf BA
Endocrinology; 2010 Nov; 151(11):5174-84. PubMed ID: 20844005
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic profiling reveals hepatic lipogenesis and liver X receptor activation in the PANDER transgenic model.
Athanason MG; Ratliff WA; Chaput D; MarElia CB; Kuehl MN; Stevens SM; Burkhardt BR
Mol Cell Endocrinol; 2016 Nov; 436():41-9. PubMed ID: 27394190
[TBL] [Abstract][Full Text] [Related]
4. Hepatic nutrient and hormonal regulation of the PANcreatic-DERived factor (PANDER) promoter.
Ratliff WA; Athanason MG; Chechele AC; Kuehl MN; Fernandez AM; MarElia CB; Burkhardt BR
Mol Cell Endocrinol; 2015 Sep; 413():101-12. PubMed ID: 26123584
[TBL] [Abstract][Full Text] [Related]
5. Enhanced glucose tolerance in pancreatic-derived factor (PANDER) knockout C57BL/6 mice.
Moak SL; Dougan GC; MarElia CB; Danse WA; Fernandez AM; Kuehl MN; Athanason MG; Burkhardt BR
Dis Model Mech; 2014 Nov; 7(11):1307-15. PubMed ID: 25217499
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function.
Robert-Cooperman CE; Carnegie JR; Wilson CG; Yang J; Cook JR; Wu J; Young RA; Wolf BA; Burkhardt BR
Diabetes; 2010 Sep; 59(9):2209-18. PubMed ID: 20566664
[TBL] [Abstract][Full Text] [Related]
7. Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting betaTC3 cells.
Cao X; Yang J; Burkhardt BR; Gao Z; Wong RK; Greene SR; Wu J; Wolf BA
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E543-50. PubMed ID: 15928025
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of pancreatic derived factor (FAM3B) expression in pancreatic β-cells by MCP-1 (CCL2).
Hou X; Wang O; Li Z; Mou H; Chen J; Deng B; Qian L; Liu X; Le Y
Mol Cell Endocrinol; 2011 Aug; 343(1-2):18-24. PubMed ID: 21664946
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells.
Yang J; Robert CE; Burkhardt BR; Young RA; Wu J; Gao Z; Wolf BA
Diabetes; 2005 Nov; 54(11):3217-28. PubMed ID: 16249448
[TBL] [Abstract][Full Text] [Related]
11. FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes.
Chi Y; Meng Y; Wang J; Yang W; Wu Z; Li M; Wang D; Gao F; Geng B; Tie L; Zhang W; Yang J
J Cell Mol Med; 2019 Mar; 23(3):1746-1758. PubMed ID: 30488666
[TBL] [Abstract][Full Text] [Related]
12. Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic β cells and liver.
Wang C; Burkhardt BR; Guan Y; Yang J
Nutr Rev; 2012 Feb; 70(2):100-6. PubMed ID: 22300596
[TBL] [Abstract][Full Text] [Related]
13. PANDER KO mice on high-fat diet are glucose intolerant yet resistant to fasting hyperglycemia and hyperinsulinemia.
Robert-Cooperman CE; Wilson CG; Burkhardt BR
FEBS Lett; 2011 May; 585(9):1345-9. PubMed ID: 21486565
[TBL] [Abstract][Full Text] [Related]
14. Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance.
Levi J; Gray SL; Speck M; Huynh FK; Babich SL; Gibson WT; Kieffer TJ
Endocrinology; 2011 Sep; 152(9):3385-95. PubMed ID: 21750049
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter.
Burkhardt BR; Yang MC; Robert CE; Greene SR; McFadden KK; Yang J; Wu J; Gao Z; Wolf BA
Biochim Biophys Acta; 2005 Sep; 1730(3):215-25. PubMed ID: 16102856
[TBL] [Abstract][Full Text] [Related]
17. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.
Andreelli F; Foretz M; Knauf C; Cani PD; Perrin C; Iglesias MA; Pillot B; Bado A; Tronche F; Mithieux G; Vaulont S; Burcelin R; Viollet B
Endocrinology; 2006 May; 147(5):2432-41. PubMed ID: 16455782
[TBL] [Abstract][Full Text] [Related]
18. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic-derived factor impaired glucagon-like Peptide-1 production from GLUTag enterendorine L-cell line and intestines.
Lai F; Chen Y; Lin H; Wang X; Zhu X; Li Y; Xiao H; Cao X
Mol Cell Endocrinol; 2017 Sep; 452():110-119. PubMed ID: 28549991
[TBL] [Abstract][Full Text] [Related]
20. PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation.
Wilson CG; Robert-Cooperman CE; Burkhardt BR
FEBS Lett; 2011 Jul; 585(14):2137-43. PubMed ID: 21664909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
